[{"id":"f0387d12-fa4e-40e1-addf-226e0d4ad5ca","acronym":"","url":"https://clinicaltrials.gov/study/NCT00900328","created_at":"2021-01-18T03:28:03.237Z","updated_at":"2024-07-02T16:37:19.075Z","phase":"","brief_title":"Study of Tumor Samples From Patients With Lung Cancer","source_id_and_acronym":"NCT00900328","lead_sponsor":"Alliance for Clinical Trials in Oncology","biomarkers":" EGFR • KRAS • ALK • TP53 • MET • CBL","pipe":" | ","alterations":" TP53 mutation • KRAS mutation • EGFR mutation • EGFR expression • MET overexpression • MET expression • CBL mutation • ALK translocation • TP53 expression • KRAS expression","tags":["EGFR • KRAS • ALK • TP53 • MET • CBL"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e TP53 mutation • KRAS mutation • EGFR mutation • EGFR expression • MET overexpression • MET expression • CBL mutation • ALK translocation • TP53 expression • KRAS expression"],"overall_status":"Completed","enrollment":" Enrollment 280","initiation":"Initiation: 09/01/2008","start_date":" 09/01/2008","primary_txt":" Primary completion: 02/01/2012","primary_completion_date":" 02/01/2012","study_txt":" Completion: 09/01/2012","study_completion_date":" 09/01/2012","last_update_posted":"2017-08-08"}]